Dr. Rishi Kakar of Segal Institute for Clinical Research Listed as an Author on Research Paper

Posted by | January 14, 2016 | Depression | No Comments

Segal Institute Logo

Segal Institute for Clinical Research’s Dr. Rishi Kakar helped to author the research paper, “A Selective Nociceptin Receptor Antagonist to Treat Depression: Evidence from Preclinical and Clinical Studies,” which was recently published in Neuropsychopharmacology. Specifically, the paper is centered around a  study that demonstrated that NOP receptors with LY2940094, translate to antidepressant efficacy in patients with major depressive disorder (MDD).


For more on this study, please read below.                                       http://www.businesswire.com/news/home/20160114006254/en


Leave a Reply

Take the first step. Contact Us

Application Received!

Thanks for submitting your application with us!

We will get in touch with you shortly.

  • Be the first to know about our new studies! You can unsubscribe at any time.

  • This field is for validation purposes and should be left unchanged.

Contact Us Now!